Last update 30 Aug 2025

MUC1-KLH vaccine adjuvanted with QS21(NCI)

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms-
Target
MUC1
Action
inhibitors
Mechanism
MUC1 inhibitors(Mucin-1 inhibitors)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal DiseasesUrogenital Diseases
Active Indication-
Inactive Indication
Breast CancerProstatic Cancer
Originator Organization
National Cancer InstituteNational Cancer Institute
Active Organization-
Inactive Organization
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with MUC1-KLH vaccine adjuvanted with QS21(NCI)
NCT00006041
/ CompletedPhase 1IIT
Vaccination of Patients Who Have Ovarian, Fallopian Tube or Peritoneal Cancer With Glycosylated MUC-1-KLH Conjugate Plus the Immunological Adjuvant QS-21
NCT00005632
/ CompletedPhase 1IIT
Vaccination of Prostate Cancer Patients With MUC-1-KLH Conjugate Plus the Immunological Adjuvant QS21: A Trial Examining the Immunogenicity of MUC-1 Glycopeptide Conjugate
NCT00004156
/ CompletedPhase 1IIT
Vaccination of High Risk Breast Cancer Patients With MUC-1 (Glycosylated) Keyhole Limpet Hemocyanin Conjugates Plus the Immunological Adjuvant QS21
100 Clinical Results associated with MUC1-KLH vaccine adjuvanted with QS21(NCI)
Login to view more data
100 Translational Medicine associated with MUC1-KLH vaccine adjuvanted with QS21(NCI)
Login to view more data
100 Patents (Medical) associated with MUC1-KLH vaccine adjuvanted with QS21(NCI)
Login to view more data
100 Deals associated with MUC1-KLH vaccine adjuvanted with QS21(NCI)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Prostatic CancerPhase 1
United States
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
01 Jun 1999
Breast CancerPhase 1
United States
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
01 May 1999
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free